comparemela.com
Home
Live Updates
Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) : comparemela.com
Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agreement
Related Keywords
United Kingdom ,
China ,
Colombia ,
Dominican Republic ,
Japan ,
Chile ,
Argentina ,
Canada ,
Israel ,
Carlo Ferri ,
Business Development ,
European Union ,
United Therapeutics Corporation ,
United Therapeutics Corporation Nasdaq ,
Interstitial Lung Disease ,
Arterial Hypertension ,
Idiopathic Pulmonary Fibrosis ,
Progressive Pulmonary Fibrosis ,
Chief Scientific ,
Business Development Officer ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.